Company profile for Unimark Remedies

PharmaCompass
Related CompaniesRelated Companies

About

Unimark, a vertically integrated healthcare company, aims in developing affordable generic medicines in various therapeutic segments such as respiratory, cardiovascular, anti-infectives, central nervous system for global markets. We believe in introducing affordable generic formulations establishing a remarkable global benchmark. Unimark has a diversified business portfolio that includes healthcare products ranging from diagnostics, devices, finished formulations, cosmeceuticals, animal healthcare products, active pharmaceutical ingredients.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
83-E, Hansraj Pragji Bldg, Off Dr. E. Moses Road, Worli, Mumbai - 400018
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

Default Event

CPhI South East Asia

Not Confirmed

envelop Contact Supplier

CPhI South East Asia

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

DATA COMPILATION #PharmaFlow

read-more
read-more
Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities
Every year, the US Food and Drug Administration (FDA) publishes the user fee amounts it will collect from manufacturers of pharmaceuticals, generic drugs, biosimilars and medical devices in the coming financial year. The fee for fiscal year 2025 under the Generic Drug User Fee Act (GDUFA) was published on July 31, 2024.The GDUFA, established in 2012, authorizes FDA to assess and collect fees from drug manufacturers to expedite the delivery of safe, high-quality, and affordable generic drugs to the American public.The FDA’s facility payments list under GDUFA reveals that as of November 14, 2024, 1,397 facilities had paid their registration fees for financial year 2025. Of these facilities, 707 or 50.6 percent are active pharmaceutical ingredients (API) facilities, 405 or 29 percent are finished dosage forms (FDF) facilities, 69 (4.9 percent) are facilities that produce both APIs and FDFs, and 216 (15.5 percent) are contract manufacturing services (CMO) sites.Teva Pharmaceuticals, with 29 facility registrations, led the list of companies, followed by Aurobindo Pharma, Sun Pharma, and Dr. Reddy's Laboratories. Fiscal year Facility Registrations 2016 1,425 2017 1,442 2018 1,269 2019 1,286 2020 1,300 2021 1,340 2022 1,385 2023 1,394 2024 1,447 2025 1,397  Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available)India continues to lead with 396 facilities, US and China follow India maintains its dominance in total facility registrations with the FDA, registering 396 facilities for FY2025. This includes 214 API facilities, 135 FDF facilities, 21 facilities engaged in both API and FDF activities, and 26 CMO facilities.The United States holds the second position with 328 facilities, while China strengthened its third position with 197 facilities.With 214 API facilities, India continues to have the largest share of API manufacturing sites, outmatching the combined total of China (128) and the US (83), which together account for 211 facilities. Among European manufacturers, Italy leads with 59 API manufacturing sites, followed by Spain (30) and Germany (25).The US has maintained its lead in FDF facilities with 143 sites, followed closely by India with 135 sites and China with 45 sites. Country API FDF Both CMO Total India 214 135 21 26 396 US 83 143 13 89 328 China 128 45 12 12 197 Italy 59 3 2 19 83 Germany 25 4 1 15 45 Spain 30 9 1 4 44 Canada 7 17   13 37 Taiwan 9 6 5 4 24 Switzerland 15 4   4 23 France 16     6 22 Japan 18   1   19 United Kingdom 12 1   2 15 Mexico 9 1   1 11 Ireland 5 5   1 11   Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) GDUFA III user fee rates increase across categories for FY25The GDUFA, which was reauthorized on September 30, 2022 (as GDUFA III), continues with provisions that will last until September 30, 2027. In July 2024, the FDA published updated user fee rates for FY2025.The facility fees have seen increases across all categories. API facility fees increased by 3 percent for domestic sites (to US$ 41,580) and 2 percent for foreign sites (to US$ 56,580). FDF facility fees rose by 5 percent for both domestic (to US$ 231,952) and foreign sites (to US$ 246,952). CMO facility fees increased by 5 percent for domestic sites (to US$ 55,668) and 4 percent for foreign sites (to US$ 70,668).Additionally, the fee for large-, medium- and small-sized drug applicants has increased by over 9 percent, compared to the 7 percent increase seen in 2023. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) China leads new facility registrations as FDA records 41 new units in FY25Out of the total 1,397 facilities registered for FY2025, 41 were new registrations (going by Facility FDA Establishment Identifier numbers). China led the way with 13 new facilities, followed closely by India with 11 new facilities, while the US secured the third position with eight new facilities.The new registrations included 15 API facilities, 13 CMO facilities, 12 FDF facilities, and one facility engaged in both API and FDF activities. Chinese companies dominated the new FDF registrations with six facilities: Chengdu Shuode Pharma, Chengdu Suncadia Medicine, Cipla (Jiangsu), GE Healthcare (Shanghai), Luoxin Aurovitas Pharma (Chengdu), and Zhejiang Xianju Pharma.India added two new FDF facilities through Eugia Steriles and Zydus Pharma. Malaysia registered two FDF facilities through Novugen Pharma and Novugen Oncology, while Turkey’s Insud Pharma subsidiary Exeltis and US’ RK Pharma registered one FDF facility each.The 13 new CMO facilities included, Acme Generics, Emcure, Esjay Pharma, Fordoz Pharma, Fourrts Laboratories, Laboratoires KABS, PharmaMax, Quality Packaging Specialists International, Ritsa Pharma, Shanghai Aucyun Pharma, Sichuan Huiyu Pharma, Taejoon Pharm, and Tubilux Pharma.In the API category, the 15 new registrations included Acharya Chemicals, Hainan Poly Pharma, CBL Patras, EUROAPI, Hybio Pharma, Medilux Laboratories, Metrochem API, Purolite, Chengdu Easton Biopharma, Sionc Pharma, Smithfield Bioscience, Xttrium Laboratories, Zhejiang Hengkang Pharma, Moehs Iberica and Shilpa Pharma. Armstrong Pharmaceuticals registered the sole facility for both APIs and FDFs.So far, 92 facilities have not renewed their registration. Among these was a facility owned by Sandoz subsidiary Eon Labs in Wilson, North Carolina (US), which is permanently closed. In fact, the geographical distribution of non-renewals shows that 30 facilities were from the US, while India and China accounted for 14 and nine non-renewals respectively. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) Our viewThe FY 2025 GDUFA facility registration data indicates a continued strong presence of Indian manufacturers in the US generic drug market, particularly in API production. However, China's leadership in new facility registrations, especially in FDF manufacturing, suggests that the global generic drug supply chain landscape may evolve considerably in the coming years. 

Impressions: 13705

https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities

#PharmaFlow by PHARMACOMPASS
21 Nov 2024

NEWS #PharmaBuzz

read-more
read-more

https://unimarkremedies.com/there-has-been-change-in-ownership-of-manage-by-shamrock-pharmagroup/

PRESS RELEASE
28 Nov 2024

http://www.hc-sc.gc.ca/dhp-mps/pubs/compli-conform/tracker-suivi-eng.php

HEALTH CANADA
20 Sep 2016

https://www.pharmacompass.com/pdf/news/unimark-remedies-limited-recieves-fda-warning-letter-1472019514.pdf

FDA
24 Aug 2016
Unimark in talks to sell carbapenen unit
Unimark in talks to sell carbapenen unit

23 Dec 2015

// Deborshi Chaki FINANCIAL EXPRESS

http://www.financialexpress.com/article/industry/companies/unimark-in-talks-to-sell-carbapenen-unit/183288/

Deborshi Chaki FINANCIAL EXPRESS
23 Dec 2015

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bionpharma-buys-25-products-from-specialty-drug-maker-banner-life-sciences/articleshow/50261016.cms

Vikas Dandekar ECONOMIC TIMES
21 Dec 2015

http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm465626.htm

FDA
28 Sep 2015

01

Albendazole

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down Click Us! arrow-down
CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

02

Benazepril Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

03

Buspirone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

04

Flecainide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

05

Lamotrigine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

06

Lisinopril

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

07

Meloxicam

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

08

Nitrofurantoin

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

09

Ramipril

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS Inactive-api JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner

10

Tigecycline

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Check the inspections & registration from this company

ABOUT THIS PAGE

Contact Unimark Remedies and get a quotation

Unimark Remedies is a supplier offers 49 products (APIs, Excipients or Intermediates).

Find a price of Albendazole bulk with DMF, WC offered by Unimark Remedies

Find a price of Benazepril Hydrochloride bulk with DMF, WC offered by Unimark Remedies

Find a price of Buspirone Hydrochloride bulk with DMF, WC offered by Unimark Remedies

Find a price of Flecainide bulk with DMF, WC offered by Unimark Remedies

Find a price of Lamotrigine bulk with DMF, WC offered by Unimark Remedies

Find a price of Lisinopril bulk with DMF, WC offered by Unimark Remedies

Find a price of Meloxicam bulk with DMF, WC offered by Unimark Remedies

Find a price of Nitrofurantoin bulk with DMF, WC offered by Unimark Remedies

Find a price of Ramipril bulk with DMF, WC offered by Unimark Remedies

Find a price of Armodafinil bulk with DMF, WC offered by Unimark Remedies

Find a price of Dronedarone Hydrochloride bulk with DMF, WC offered by Unimark Remedies

Find a price of Febuxostat bulk with DMF, WC offered by Unimark Remedies

Find a price of Lanthanum Carbonate bulk with DMF, WC offered by Unimark Remedies

Find a price of Montelukast Sodium bulk with WC offered by Unimark Remedies

Find a price of Moxifloxacin Hydrochloride bulk with DMF, WC offered by Unimark Remedies

Find a price of Paliperidone bulk with DMF, WC offered by Unimark Remedies

Find a price of Pimozide bulk with DMF, WC offered by Unimark Remedies

Find a price of Rizatriptan Benzoate bulk with DMF, WC offered by Unimark Remedies

Find a price of Solifenacin Succinate bulk with DMF, WC offered by Unimark Remedies

Find a price of Tigecycline bulk with DMF, WC offered by Unimark Remedies

Find a price of Topiramate bulk with DMF, WC offered by Unimark Remedies

Find a price of Candesartan Cilexetil bulk with WC offered by Unimark Remedies

Find a price of Cefixime bulk with DMF offered by Unimark Remedies

Find a price of Cefuroxime Axetil bulk with DMF offered by Unimark Remedies

Find a price of Flecainide bulk with DMF offered by Unimark Remedies

Find a price of Hydroxychloroquine Sulphate bulk with WC offered by Unimark Remedies

Find a price of Meropenem bulk with DMF offered by Unimark Remedies

Find a price of Nalidixic Acid bulk with WC offered by Unimark Remedies

Find a price of Nitrofurantoin bulk with DMF offered by Unimark Remedies

Find a price of Tenofovir Disoproxil Fumarate bulk with WC offered by Unimark Remedies

Find a price of 7-Amino-3-Vinyl-3-Cephem-4-Carboxylic Acid bulk with DMF offered by Unimark Remedies

Find a price of Atazanavir Sulfate bulk with WC offered by Unimark Remedies

Find a price of CAS 491878-06-9 bulk with DMF offered by Unimark Remedies

Find a price of Cilastatin Sodium bulk with DMF offered by Unimark Remedies

Find a price of Doripenem bulk with DMF offered by Unimark Remedies

Find a price of Ganciclovir bulk with WC offered by Unimark Remedies

Find a price of Imipenem bulk with DMF offered by Unimark Remedies

Find a price of Montelukast Sodium bulk with DMF offered by Unimark Remedies

Find a price of Montelukast Sodium bulk offered by Unimark Remedies

Find a price of Topiramate bulk with DMF offered by Unimark Remedies

Find a price of Cefaclor bulk offered by Unimark Remedies

Find a price of Cefprozil bulk offered by Unimark Remedies

Find a price of Cephalexin bulk offered by Unimark Remedies

Find a price of Cephalexin Monohydrate bulk offered by Unimark Remedies

Find a price of Darifenacin Hydrobromide bulk offered by Unimark Remedies

Find a price of Eszopiclone bulk offered by Unimark Remedies

Find a price of Nimesulide bulk offered by Unimark Remedies

Find a price of Olmesartan Medoxomil bulk offered by Unimark Remedies

Find a price of Propofol bulk offered by Unimark Remedies

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty